• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005-2015 年英格兰慢性呼吸道疾病患者死因变化。

Changing causes of death for patients with chronic respiratory disease in England, 2005-2015.

机构信息

Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College London, London, UK.

Market Access, Boehringer Ingelheim Ltd, Bracknell, UK.

出版信息

Thorax. 2019 May;74(5):483-491. doi: 10.1136/thoraxjnl-2018-212514. Epub 2019 Jan 29.

DOI:10.1136/thoraxjnl-2018-212514
PMID:30696745
Abstract

BACKGROUND

Chronic respiratory diseases (CRD) are common, are increasing in prevalence, and cause significant morbidity and mortality worldwide. However, we have limited knowledge on causes of death of patients with CRD in the general population.

OBJECTIVE

We evaluated mortality rates and causes of death over time in patients with CRD.

METHODS

We used linked primary care and mortality data to determine mortality rates and the most common causes of death in people with CRD (including asthma, bronchiectasis, COPD and interstitial lung diseases (ILD)) during 2005-2015 in England.

RESULTS

We identified 558 888 patients with CRD (451 830 asthma, 137 709 COPD, 19 374 bronchiectasis, 10 745 ILD). The age-standardised mortality rate of patients with CRD was 1607 per 100 000 persons (asthma=856, COPD=1503, ILD=2609, bronchiectasis=1463). CRD mortality was overall 54% higher than the general population. A third of patients with CRD died from respiratory-related causes. Respiratory-related mortality was constant, while cardiovascular-related mortality decreased significantly over time. COPD accounted for the majority of respiratory-related deaths (66% overall) in all patient groups except ILD.

CONCLUSIONS

Patients with CRD continue to experience substantial morbidity and mortality due to respiratory diseases. Disease-modifying intervention strategies are needed to improve outcomes for patients with CRD.

摘要

背景

慢性呼吸道疾病(CRD)较为常见,且其发病率在全球范围内呈上升趋势,导致了大量的发病率和死亡率。然而,我们对普通人群中 CRD 患者的死因知之甚少。

目的

评估 CRD 患者随时间推移的死亡率和死因。

方法

我们使用了关联的初级保健和死亡率数据,以确定在 2005 年至 2015 年期间,英格兰患有 CRD(包括哮喘、支气管扩张症、COPD 和间质性肺疾病(ILD))的患者的死亡率和最常见的死因。

结果

我们确定了 558888 例 CRD 患者(451830 例哮喘、137709 例 COPD、19374 例支气管扩张症、10745 例 ILD)。CRD 患者的年龄标准化死亡率为每 100000 人中有 1607 人(哮喘=856,COPD=1503,ILD=2609,支气管扩张症=1463)。CRD 的总体死亡率比普通人群高出 54%。三分之一的 CRD 患者死于与呼吸相关的原因。与呼吸相关的死亡率保持不变,而心血管相关的死亡率随着时间的推移显著下降。除了 ILD 之外,在所有患者群体中,COPD 都导致了大多数与呼吸相关的死亡(总体占 66%)。

结论

CRD 患者继续因呼吸疾病而遭受大量的发病率和死亡率。需要采取疾病修正干预策略来改善 CRD 患者的结局。

相似文献

1
Changing causes of death for patients with chronic respiratory disease in England, 2005-2015.2005-2015 年英格兰慢性呼吸道疾病患者死因变化。
Thorax. 2019 May;74(5):483-491. doi: 10.1136/thoraxjnl-2018-212514. Epub 2019 Jan 29.
2
Patient pathways for four major chronic respiratory diseases in England between 2008 and 2021.2008 年至 2021 年期间英格兰四种主要慢性呼吸道疾病的患者路径。
BMJ Open Respir Res. 2024 Aug 28;11(1):e002273. doi: 10.1136/bmjresp-2023-002273.
3
Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis.哮喘和 COPD 患者的呼吸相关死亡:竞争风险分析。
BMC Pulm Med. 2022 Jan 8;22(1):28. doi: 10.1186/s12890-022-01823-4.
4
Multicity study of air pollution and mortality in Latin America (the ESCALA study).拉丁美洲空气污染与死亡率的多城市研究(ESCALA研究)。
Res Rep Health Eff Inst. 2012 Oct(171):5-86.
5
Trends, patterns and causes of respiratory disease mortality among inpatients in Tanzania, 2006-2015.坦桑尼亚 2006-2015 年住院患者呼吸系统疾病死亡率的趋势、模式和原因。
Trop Med Int Health. 2019 Jan;24(1):91-100. doi: 10.1111/tmi.13165. Epub 2018 Nov 8.
6
Association of Cardiovascular Disease With Respiratory Disease.心血管疾病与呼吸疾病的关联。
J Am Coll Cardiol. 2019 May 7;73(17):2166-2177. doi: 10.1016/j.jacc.2018.11.063. Epub 2019 Mar 4.
7
Trends in Prevalence and Prognosis in Subjects With Acute Chronic Respiratory Failure Treated With Noninvasive and/or Invasive Ventilation.接受无创和/或有创通气治疗的急性慢性呼吸衰竭患者的患病率和预后趋势。
Respir Care. 2015 Feb;60(2):210-8. doi: 10.4187/respcare.03467. Epub 2014 Nov 18.
8
Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease.新冠病毒感染后合并和不合并慢性呼吸道疾病人群的心血管事件风险。
Int J Epidemiol. 2024 Apr 11;53(3). doi: 10.1093/ije/dyae068.
9
Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors.哪些晚期呼吸系统疾病患者会在医院死亡?一项基于人群的14年趋势及相关因素研究。
BMC Med. 2017 Feb 1;15(1):19. doi: 10.1186/s12916-016-0776-2.
10
Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014.1980 - 2014年美国各县慢性呼吸道疾病死亡率差异的趋势与模式
JAMA. 2017 Sep 26;318(12):1136-1149. doi: 10.1001/jama.2017.11747.

引用本文的文献

1
Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD.慢性阻塞性肺疾病(COPD)患者住院后的主要不良心血管事件及特定病因死亡率
Int J Chron Obstruct Pulmon Dis. 2025 Jul 19;20:2549-2560. doi: 10.2147/COPD.S529171. eCollection 2025.
2
Trends, seasonal variations and forecasting of chronic respiratory disease morbidity in charcoal producing areas, northwest Ethiopia: time series analysis.埃塞俄比亚西北部木炭生产地区慢性呼吸道疾病发病率的趋势、季节性变化及预测:时间序列分析
Front Epidemiol. 2025 Jan 15;4:1498203. doi: 10.3389/fepid.2024.1498203. eCollection 2024.
3
UK Electronic Healthcare Records for Research: A Scientometric Analysis of Respiratory, Cardiovascular, and COVID-19 Publications.
英国用于研究的电子医疗记录:呼吸、心血管及新冠病毒疾病出版物的科学计量分析
Pragmat Obs Res. 2024 Aug 15;15:151-164. doi: 10.2147/POR.S469973. eCollection 2024.
4
All-cause and cause-specific mortality by spirometric pattern and sex - a population-based cohort study.基于肺活量测定模式和性别的全因死亡率及特定病因死亡率——一项基于人群的队列研究
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241232768. doi: 10.1177/17534666241232768.
5
Correlation between serum iron levels and pulmonary function: A cross-sectional analysis based on NHANES database 5319 cases.血清铁水平与肺功能的相关性:基于 NHANES 数据库 5319 例的横断面分析。
Medicine (Baltimore). 2023 Dec 15;102(50):e36449. doi: 10.1097/MD.0000000000036449.
6
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study.运用CONQUEST质量标准确定英国高危慢性阻塞性肺疾病患者优化管理的关键机会:一项观察性纵向研究
Lancet Reg Health Eur. 2023 Apr 21;29:100619. doi: 10.1016/j.lanepe.2023.100619. eCollection 2023 Jun.
7
Supplementation of serum albumin is associated with improved pulmonary function: NHANES 2013-2014.补充血清白蛋白与肺功能改善相关:2013 - 2014年美国国家健康与营养检查调查(NHANES)
Front Physiol. 2022 Oct 3;13:948370. doi: 10.3389/fphys.2022.948370. eCollection 2022.
8
Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.COVID-19 大流行期间与慢性阻塞性肺疾病相关的死亡率:意大利威尼托地区通过不同流行波分析多种死亡原因。
Int J Environ Res Public Health. 2022 Oct 7;19(19):12844. doi: 10.3390/ijerph191912844.
9
Are we missing lifetime COPD diagnosis among people with COPD recorded death? A population-based retrospective cohort study.在记录有慢性阻塞性肺疾病(COPD)死亡的人群中,我们是否遗漏了终生COPD诊断?一项基于人群的回顾性队列研究。
BJGP Open. 2022 Dec 20;6(4). doi: 10.3399/BJGPO.2022.0060. Print 2022 Dec.
10
Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.用于呼吸系统疾病的吸入式小干扰RNA制剂:从基础研究到临床应用
Pharmaceutics. 2022 Jun 2;14(6):1193. doi: 10.3390/pharmaceutics14061193.